Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-23-045329

CEO disposed of 11,227 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Gline Matthew CEO 2023-09-22 Other disposition −11,227 $10.19 $114,403 1,033,721 D
Loading xslF345X05/form4.xml…